Articles tagged with Bleeding
Researchers found that patients had the same success rate when treated for 24 hours compared to 72 hours, with no difference in need for transfusion, ventilation, or vasopressors. This suggests that shorter octreotide therapy may be sufficient and could help reduce hospital stays and costs.
A recent study published in The American Journal of Clinical Nutrition found that over 80% of women are iron deficient by the third trimester of pregnancy. Despite being considered a high-resource setting, the study revealed alarming rates of iron deficiency among healthy pregnant women. This finding emphasizes the importance of routin...
A single-dose gene therapy has been shown to significantly reduce bleeding episodes in adults with hemophilia B, with an average reduction of 71% compared to standard treatment. The therapy, which enables the liver to produce clotting factor IX, has been FDA-approved for use in patients with this genetic disorder.
A nationwide cohort study revealed a higher risk of placental problems, premature births, and severe bleeding in subsequent deliveries following uterine artery embolization. Babies born to mothers who underwent UAE also had a higher chance of major birth defects, particularly heart problems.
Researchers found pomalidomide to be safe and effective in reducing nosebleed severity, improving quality of life, and decreasing the need for blood transfusions in adults with hereditary hemorrhagic telangiectasia. The trial stopped early due to successful findings, offering a promising treatment option for this rare bleeding disorder.
A clinical trial found that an oral cancer drug reduced nosebleed severity and improved quality of life in patients with hereditary hemorrhagic telangiectasia (HHT). The PATH-HHT study showed significant improvements in disease manifestations, including severe nosebleeds and chronic gastrointestinal bleeding.
A phase III trial found that asundexian was inferior to apixaban in preventing stroke and systemic embolism in high-risk patients with atrial fibrillation. The trial also showed lower bleeding rates with asundexian, but this finding needs to be put into context with the stroke findings.
A study by the University of Gothenburg finds that removing Fallopian tubes during laparoscopic sterilization results in marginally more surgical complications than cutting them. The procedure may help protect against future ovarian cancer, a serious disease with limited early symptoms.
A recent study published by Florida Atlantic University found that occasional alcohol use increases the odds of intracranial hemorrhage by double when compared to those who do not drink. Daily alcohol consumption is associated with a 150% increased risk of brain bleeds from falls.
A study by Michigan Medicine found that over- or under-dosing anticoagulants can result in serious health conditions, most often occurring after the initial prescription. The researchers evaluated five years of prescribing data and found that nearly 70% of alerts to off-label dosing occurred during a follow-up visit.
A new study suggests that more than one-third of women do not recognize postmenopausal bleeding as a key symptom, and many healthcare professionals lack adequate education on the subject. The findings highlight the need for improved patient counseling about abnormal uterine bleeding as an early warning sign of endometrial cancer.
A study published in JAMA Network Open found that years of high systolic blood pressure increase the risk of stroke, with Black and Hispanic patients facing a higher risk. Early diagnosis and controlled high blood pressure are crucial to preventing stroke, especially in these populations.
Researchers have identified a link between tissue shrinkage and blood vessel stretching that contributes to intraventricular hemorrhage in premature newborns. Altering the activity of certain salt and water transporters may prevent this condition.
A global study and meta-analysis confirm pantoprazole's effectiveness in preventing upper GI bleeding in critically ill adults on a breathing machine. The research, led by McMaster University, shows that pantoprazole reduces the risk of clinically important upper GI bleeding but has no significant impact on mortality.
A lifesaving package of interventions to objectively identify and treat post-partum haemorrhage (PPH) has been found to be highly cost-effective, incurring minimal additional cost. The intervention resulted in over 1000 fewer PPH cases compared to usual care, with an estimated average additional cost of $0.30 per patient.
Patients with atrial fibrillation who took low doses of direct oral anticoagulants experienced more bleeding episodes during the first three months of treatment. High blood levels of the medications were also associated with an increased risk of bleeding events.
Patients with intracerebral hemorrhage have better medical outcomes when surgeons perform early minimally invasive removal of a hematoma compared to standard care. The study found improved survival rates and functional outcomes at 180 days for patients who received early surgical intervention.
Researchers assessed brain imaging for minor, moderate, and major ischemic strokes to evaluate early direct oral anticoagulant initiation. The study found no difference in treatment effects or adverse event rates among infarct sizes.
A breakthrough in trauma care has nearly quadrupled the 'golden hour' for treating large animals with internal bleeding during emergency ground and air transport. Researchers used a closed-loop, autonomous intervention system to resuscitate pigs with traumatic injuries, extending their survival time by several hours.
A team of researchers has developed a hemostasis sponge that swiftly staunchs kidney bleeding and facilitates wound recovery. The material uses kidney-derived decellularized extracellular matrix to recreate the kidney's microenvironment, boasting high biocompatibility.
A new anticoagulant with on-demand reversible activity has been developed by a team from UNIGE and the University of Sydney. This breakthrough offers a more reliable and easier-to-use option for surgical procedures, reducing the risk of serious bleeding associated with current treatments.
Researchers discovered that certain bacteria, including Salmonella enterica and Escherichia coli, are attracted to human serum, which contains the amino acid serine. This phenomenon, known as bacterial vampirism, allows the bacteria to navigate towards the source of blood in under a minute.
Researchers at Case Western Reserve, UNC/NCSU, and Pitt aim to develop an injectable nanotechnology that mimics platelet function to stabilize blood clots in traumatic injuries. The technology has the potential to stop hemorrhage and improve survival rates in emergency situations.
A new study shows that a massive effort to reduce the overuse of proton pump inhibitors (PPIs) led to a nearly 30% reduction in prescriptions, but also resulted in some veterans missing out on protective use. The intervention, which imposed limits on PPI prescription size and refills, was carried out in one region of the Veterans Healt...
Synthetic platelets made of hydrogel nanoparticles mimic the size and shape of human platelets, promoting clotting and healing. The innovative device has shown promising results in animal models and is being developed for clinical use to treat various medical conditions.
Researchers found that withdrawing aspirin one month after PCI significantly reduced major and minor bleeding incidents by 55% compared to dual antiplatelet therapy. The study, ULTIMATE-DAPT, showed no increase in adverse ischemic events, suggesting continuing aspirin may cause harm without benefit.
Caterpillars of the Carolina sphinx moth have an extraordinary ability to instantly change their hemolymph's material properties, turning it into a viscoelastic fluid that helps stop bleeding. This discovery has potential applications for developing new drugs for humans to create fast-working thickeners of human blood.
A study published in Critical Care identified eight different trauma phenotypes associated with lower in-hospital mortality when treated with tranexamic acid. The researchers used a machine learning model to analyze data from over 50,000 patients and found subgroups of patients who received no benefit from treatment.
Researchers found that nontraditional stroke risk factors like migraines are as important as traditional risk factors like high blood pressure for adults younger than ages 35-45. The association between stroke and nontraditional stroke risk factors was stronger in adults younger than 35 years old.
The Sylvester Comprehensive Cancer Center researchers will investigate the genetics behind endometrial cancer in Black women and its awareness among different populations. They aim to identify high-risk women, understand hereditary mutations, and raise physician awareness.
Researchers at Brigham and Women's Hospital developed a sprayable adhesive hydrogel product to address GI wound management limitations. The material promotes rapid wound healing, provides tissue protection, and minimizes complications under harsh conditions.
The study found that patient outcomes for six critical conditions worsened at urban hospitals, while rural hospitals experienced smaller declines, highlighting the need for tailored strategies to reduce excess deaths in future crises.
A new poll suggests that more than half of people aged 50-80 taking aspirin don't have cardiovascular disease, raising concerns about the effectiveness of routine aspirin use. Guidelines now focus on those with a history of cardiovascular issues or high risk due to personal health and family history.
Earlier anticoagulation reversal is associated with improved outcomes after intracerebral hemorrhage, supporting efforts to accelerate evaluation and treatment. This study supports intensive care strategies to improve survival rates among patients with this devastating form of stroke.
Researchers found that adding blood thinners to clot-busting medications for ischemic strokes did not improve physical function at 90 days post-stroke. The study, MOST, enrolled 514 patients and analyzed the effectiveness of two blood-thinning medications.
A recent study published in Hepatology has investigated the connection between platelet function and complications in patients with cirrhosis. The researchers found that decreased platelet activation predicts hepatic decompensation and mortality, highlighting the importance of personalized therapeutic approaches.
Researchers discovered two new genetic pathways associated with worse ICH outcomes, including a pathway affecting blood coagulation and cellular interactions. Population data showed a decrease in aneurysmal SAH strokes and a rise in non-aneurysmal subarachnoid hemorrhages, offering encouraging evidence for intervention success.
A preliminary study found that most stroke survivors can safely take two common types of antidepressants without increasing the risk of hemorrhagic stroke. However, patients on dual anti-platelet therapy may be at increased risk of bleeding.
A study of over 1,700 adult patients found that gastric bypass and sleeve surgeries have few short-term complications and are equivalent in terms of risk. The results suggest that patients and doctors can choose between the two procedures without worrying about short-term surgical risks.
Researchers at University of Tsukuba discovered a correlation between hypoxia levels and clinical symptoms in UC patients. Lower oxygen saturation in the rectal mucosa was associated with greater severity of colitis, making this method a potential tool for objective measurement of disease activity.
Researchers developed a porous, chitosan-based material that rapidly absorbs blood and activates clotting mechanisms, halting bleeding within minutes. The 'hemostat' offers a more effective alternative to traditional compression methods, which can take over two hours to stop bleeding.
Researchers found that bleeding control kits should be placed in two or more locations on premises, with a walking distance of under 90 seconds. Located near AEDs is more beneficial than at entrances, where they may be difficult to reach.
Researchers found rivaroxaban associated with nearly 40 bleeding events per 100 patients over a year, while apixaban had similar bleeding events as warfarin but more major bleeds. Apixaban also showed lower mortality rates compared to the other medications.
A novel technique to test platelet function within a person's blood sample is faster, easier and more precise than methods currently in use. The technology has the potential to assess the effects of antiplatelet drugs on individuals and gain a clearer picture of bleeding risks for patients undergoing cardiopulmonary bypass surgery.
A Mayo Clinic study found that patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and decreased risk of blood clots. The use of warfarin was associated with a 32% reduction in mortality risk, making it an effective treatment for these patients.
Researchers at Temple University Health System report that the BASHIR Endovascular Catheter reduces blockages in lung arteries and correlates with improved right ventricle function, suggesting better survival outcomes. The catheter also shows significantly lower bleeding rates compared to other devices.
A randomized clinical trial found that excluding aspirin from the antithrombotic regimen in LVAD patients improved adverse event rates by a significant reduction in non-surgical bleeding. The study results suggest that an aspirin-free regimen is safe and may improve longevity, morbidity, and quality of life for these patients.
A literature review found that prioritizing circulation before the airway in trauma patients with major blood loss leads to improved outcomes, including lower mortality rates. This approach, known as CAB, has gained acceptance over the ABC model and is now being recommended by the American College of Surgeons.
Researchers discovered that apotransferrin can mitigate the damaging effects of intracerebral haemorrhage by guarding against ferropoptosis, a cell death process. This finding highlights the therapeutic potential of apotransferrin as a pre-hospital treatment for stroke patients.
A groundbreaking study published in JAMA found that excluding aspirin from the antithrombotic regimen for patients with a fully magnetically levitated left ventricular assist device (LVAD) resulted in a significant decrease in major nonsurgical bleeding events. This approach is safe and beneficial, challenging conventional practice and...
A new UK study found that 1 in 3000 patients experience cardiac arrest requiring resuscitation during anaesthesia. The study, which included data from over 300 hospitals, identified significant factors contributing to perioperative cardiac arrests.
Researchers found that removing aspirin from treatment while continuing vitamin-k antagonists in patients with modern left ventricular assist devices (LVADs) did not increase clotting-related risks or pump malfunctions. Aspirin avoidance was associated with a reduction in bleeding events, lower hospital days, and decreased cost of care.
Researchers developed a new risk assessment system to identify patients with low-risk profiles who can benefit from liver stents. These patients have a significantly higher mortality rate than previously thought, highlighting the need for targeted treatment and further personalization.
A global study found that apixaban reduced the risk of stroke and blood clotting by 37% in patients with device-detected atrial fibrillation, also known as sub-clinical atrial fibrillation (SCAF). The medication also reduced fatal or disabling stroke by 49%.
A phase 4 clinical trial found that apixaban, an anti-clotting medication, reduced the rate of stroke and blood clots in adults with implanted heart devices experiencing short bouts of asymptomatic, irregular heart rhythms. The study suggests that these individuals may benefit from receiving an anticoagulant.
Researchers found that abelacimab, a Factor XI inhibitor, reduced bleeding compared to rivaroxaban in patients with atrial fibrillation. The study showed significant reduction in hospitalization due to bleeding and almost eliminated gastrointestinal bleeding.
A new anti-clotting medication, abelacimab, has significantly reduced bleeding among people with atrial fibrillation who are at risk of stroke. The AZALEA-TIMI 71 trial found that abelacimab substantially reduced bleeding compared to the current standard of care use of direct-acting oral anticoagulants.
A randomized clinical trial found that avoiding aspirin as part of an antithrombotic regimen reduces bleeding events without increasing thromboembolism risk in patients with advanced heart failure treated with left ventricular assist devices. The study suggests that aspirin avoidance may be a viable option for these patients.
A recent study in JAMA Cardiology analyzed data from 15,000 patients and found that enteric coating on aspirin does not change its effectiveness or safety for secondary prevention of cardiovascular events. The study suggests that patients can choose the aspirin formulation that suits them best.
Postoperative wound infections in the head and neck region are common complications, with risk factors including age, smoking, and comorbidities. Aseptic operating conditions and peri/postoperative antibiotics can help minimize infection rates.